Attached files
| file | filename |
|---|---|
| EX-31.1 - CERTIFICATION - 180 Life Sciences Corp. | f10k2019ex31-1_kblmerge.htm |
| EX-4.6 - DESCRIPTION OF THE REGISTRANT'S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF - 180 Life Sciences Corp. | f10k2019ex4-6_kblmerger.htm |
| 10-K - ANNUAL REPORT - 180 Life Sciences Corp. | f10k2019_kblmergercorp4.htm |
Exhibit 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADDED BY
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report of KBL Merger Corp. IV (the “Company”) on Form 10-K for the year ended December 31, 2019, as filed with the Securities and Exchange Commission (the “Report”), I, Marlene Krauss, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as added by §906 of the Sarbanes-Oxley Act of 2002, that:
| 1. | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
| 2. | To my knowledge, the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of and for the period covered by the Report. |
| Date: April 7, 2020 | By: | /s/ Marlene Krauss |
| Marlene Krauss | ||
Chief Executive Officer (Principal
Executive Officer and |